Loading...
Rapamycin, by Inhibiting mTORC1 Signaling, Prevents the Loss of Striatal Bidirectional Synaptic Plasticity in a Rat Model of L-DOPA-Induced Dyskinesia
Levodopa (L-DOPA) treatment is the main gold-standard therapy for Parkinson disease (PD). Besides good antiparkinsonian effects, prolonged use of this drug is associated to the development of involuntary movements known as L-DOPA-induced dyskinesia (LID). L-DOPA-induced dyskinesia is linked to a sen...
Na minha lista:
| Udgivet i: | Front Aging Neurosci |
|---|---|
| Main Authors: | , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Frontiers Media S.A.
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7431470/ https://ncbi.nlm.nih.gov/pubmed/32848709 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fnagi.2020.00230 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|